Home/Filings/4/0001437749-21-013592
4//SEC Filing

Schaffer Paul W. 4

Accession 0001437749-21-013592

CIK 0001029125other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 8:49 PM ET

Size

7.5 KB

Accession

0001437749-21-013592

Insider Transaction Report

Form 4
Period: 2021-05-25
Transactions
  • Award

    Common Stock

    2021-05-25+4,316166,671 total
  • Award

    Stock Option (right to buy)

    2021-05-25+12,36812,368 total
    Exercise: $4.17Exp: 2031-05-25Common Stock (12,368 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    30,665
Footnotes (2)
  • [F1]Includes 60 shares of common stock found to be held by the reporting person as a result of a reconciliation of Issuer records.
  • [F2]Scheduled to vest and become exercisable in four equal increments on August 25, 2021, November 24, 2021, February 25, 2022 and the earlier of May 31, 2022 and the day before the company's annual meeting of stockholders to be held in 2022.

Issuer

Panbela Therapeutics, Inc.

CIK 0001029125

Entity typeother

Related Parties

1
  • filerCIK 0001652797

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 8:49 PM ET
Size
7.5 KB